US equities
|
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
SNDK
$1,704.16
▲+0.00%
AMD
$631.75
▲+0.00%
SDEV
$3.94
▲+0.00%
SKHY
$195.02
▲+0.00%
TSLA
$378.73
▲+0.00%
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
SNDK
$1,704.16
▲+0.00%
AMD
$631.75
▲+0.00%
SDEV
$3.94
▲+0.00%
SKHY
$195.02
▲+0.00%
TSLA
$378.73
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cabaletta Bio, Inc. - Common Stock
(NQ:
CABA
)
2.080
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cabaletta Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
↗
August 11, 2025
Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA vaccine oversight.
Via
Benzinga
Cabaletta Bio (CABA) Q2 Loss Widens 30%
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From
Cabaletta Bio
Via
GlobeNewswire
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
↗
July 30, 2025
Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.
Via
Benzinga
Looking Into Cabaletta Bio's Recent Short Interest
↗
January 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 23, 2025
Via
Benzinga
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
↗
June 30, 2025
FDA lifts REMS for approved CAR-T therapies, easing hospital restrictions and signaling broader future access in oncology and autoimmune treatment.
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
June 11, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 11, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session.
↗
June 11, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Which stocks are gapping on Wednesday?
↗
June 11, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Cabaletta Bio Announces Pricing of Public Offering of Securities
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 11, 2025
Via
Benzinga
Cabaletta Bio Announces Proposed Public Offering of Securities
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
June 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
May 29, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Top movers in Friday's pre-market session
↗
May 16, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
May 16, 2025
Via
Benzinga
Cabaletta Bio Stock Surges To 2-Month High On Autoimmune Therapy Progress; Retail’s Pleased
↗
May 15, 2025
The company announced the addition of two subtype-specific cohorts to its RESET-Myositis trial and received RMAT designation from the FDA for rese-cel.
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 15, 2025
Via
Benzinga
These stocks are gapping in today's session
↗
May 15, 2025
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
May 15, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 31, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cellares and Cabaletta Bio Successfully Complete Manufacturing Technology Adoption Program for Rese-cel Using the Cell Shuttle™ Platform
March 19, 2025
From
Cellares
Via
Business Wire
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
February 26, 2025
From
Cabaletta Bio
Via
GlobeNewswire
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
February 11, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
January 29, 2025
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
January 13, 2025
From
Cabaletta Bio
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
